Genomic surveillance of invasive Neisseria meningitidis isolates circulating in Paraguay, 2009-2021

María Eugenia León1, Anibal Yasunari Kawabata2, Cristina Minako Nagai1

  • 1Department of Bacteriology and Mycology, Central Public Health Laboratory (LCSP), Asunción, Paraguay.

Abstract

Insights

This study analyzed invasive meningococcal disease (IMD) isolates in Paraguay using whole-genome sequencing. Most isolates belonged to clonal complex 103, with variations in vaccine antigens and high rates of antimicrobial resistance genes.

Area of Science:

  • Genomics
  • Microbiology
  • Public Health

Background:

  • Invasive meningococcal disease (IMD) is a significant global health threat.
  • IMD poses a continuous challenge in Paraguay, necessitating detailed epidemiological surveillance.
  • Understanding the genetic makeup of Neisseria meningitidis is crucial for disease control.

Purpose of the Study:

  • To conduct the first genomic analysis of Neisseria meningitidis isolates in Paraguay.
  • To characterize the genetic diversity, vaccine antigen profiles, and antimicrobial resistance of IMD-causing strains.
  • To inform public health strategies for IMD prevention and control in the region.

Main Methods:

  • Retrospective, descriptive, cross-sectional observational study design.
  • Whole-genome sequencing of Neisseria meningitidis isolates from IMD cases (2009-2021).
  • Multilocus sequence typing (MLST), vaccine antigen characterization, and antimicrobial resistance profiling.

Main Results:

  • Eight clonal complexes (CCs) identified, with CC103 being the most prevalent.
  • Variations in vaccine antigen coverage were observed, with some key peptides absent or present at low frequencies.
  • High prevalence (73.7%) of mutated penA alleles, indicating potential antimicrobial resistance.

Conclusions:

  • This genomic study provides novel insights into the genetic landscape of invasive meningococcal isolates in Paraguay.
  • Genomic data are vital for tracking circulating strains and potential immune evasion mechanisms.
  • Findings highlight the need for ongoing genomic surveillance to adapt vaccination and treatment strategies.